Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dai, Yong
NCT05555901: The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer	Recruiting	2	116	RoW	Fruquintinib+ chemotherapy, Bevacizumab+ chemotherapy	Fudan University	Metastatic Colorectal Cancer	09/25	09/25
NACSOC, NCT02972541: Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer	Recruiting	N/A	248	RoW	Stenting with neoadjuvant chemotherapy, Stenting with immediate Surgery	Beijing Chao Yang Hospital	Colorectal Cancer, Neoadjuvant Chemotherapy, Stent, Obstruction	12/23	12/23